Healthcare-associated infections (HAIs) present a significant, ongoing threat to the health industry worldwide, representing between 5-10% of all hospital admissions and contributing to roughly 90,000 fatalities annually in the U.S. alone. Key players standing at the frontlines in the battle against HAIs are clinical microbiologists, serving an essential role in the early detection and therefore prevention of such hazardous infections. Their contribution in this arena is multi-dimensional, encompassing: disease surveillance, outbreak management, antibiotic usage, contributions to infection control committees, and education and training initiatives.
In the context of disease surveillance, where the objective is the swift and accurate identification of HAIs and associate resistance patterns, clinical microbiologists are frequently challenged by the emerging novel infectious agents and newly developing antibiotic-resistant pathogens. Another related challenge is the necessity for active surveillance and timely reporting of HAI case occurrences. It’s thus essential that these specialists forge strong liaisons with information technology departments and infection prevention and control (IPC) programs.
When it comes to managing and detecting outbreaks, clinical microbiologists are fundamental to recognising potential clusters and epidemics early, and ensuring prompt notifications and coordinating actions with IPC units. They must be prepared for challenges such as the retroactive identification of outbreaks and the possibility of pseudo-outbreaks due to contaminations inside or outside the lab.
While antibiotic usage is a crucial aspect of infection control, the delayed availability of antibiotic susceptibility data can hinder its effectiveness. To counter this, continuous communication is required between the clinical pharmacology, IPC, and stewardship teams. Antimicrobial stewardship programs are an essential part of healthcare systems, promoting the prudent use of antimicrobials.
When it comes to infection control committees, clinical microbiologists must assume a consulting role for those involved in infection prevention initiatives. They also play a vital part in training hospital epidemiologists and infection prevention staff, thereby contributing to the overall institutional knowledge base on infection control.
Given the crucial role of clinical microbiologists, it is essential that proper funding is provided to support necessary laboratory functions. Shoring up quality assurance processes and carrying out external quality control on important operations can make a significant difference in minimizing the risk of HAIs.
In conclusion, the roles filled by clinical microbiologists in diagnosing patient infections and preventing HAIs are invaluable. Through them, severe HAIs can be effectively combatted, ensuring patients receive appropriate care and healthcare providers reduce both costs and potential loss of life.
Source: https://www.selectscience.net/article/the-role-of-clinical-microbiologists-in-hais-amr-and-beyond